Search

Your search keyword '"Express Scripts Inc. -- Prices and rates"' showing total 15 results
Start Over Descriptor "Express Scripts Inc. -- Prices and rates"
15 results on '"Express Scripts Inc. -- Prices and rates"'

1. FTC sues CVS, Cigna, UnitedHealth over insulin drug prices

Subjects
United States. Federal Trade Commission, CVS Health Corp. -- Prices and rates, CIGNA Corp. -- Prices and rates, Caremark Rx Inc. -- Prices and rates, Express Scripts Inc. -- Prices and rates, UnitedHealth Group Inc. -- Prices and rates, Health maintenance organizations -- Prices and rates, Diabetes therapy -- Prices and rates, Drugs -- Prescribing, Drugstores -- Prices and rates, Group purchasing organizations, Insulin -- Prices and rates, Company pricing policy, Business, News, opinion and commentary
Abstract

The Federal Trade Commission said it brought action against the three largest prescription drug benefit managers - CVS Health's (CVS) Caremark Rx, Cigna's (CI) Express Scripts and UnitedHealth's (UNH) OptumRx, [...]

Published
2024

2. FTC Sues Prescription Drug Middlemen for Artificially Inflating Insulin Drug Prices

Subjects
United States. Federal Trade Commission, CVS Health Corp. -- Prices and rates, CIGNA Corp. -- Prices and rates, Caremark Rx Inc. -- Prices and rates, Express Scripts Inc. -- Prices and rates, UnitedHealth Group Inc. -- Prices and rates, Health maintenance organizations -- Prices and rates, Diabetes therapy -- Prices and rates, Restraint of trade, Drugs -- Prescribing, Drugstores -- Prices and rates, Group purchasing organizations, Insulin -- Prices and rates, Company pricing policy, News, opinion and commentary
Abstract

Washington, D.C.: US Federal Trade Commission has issued the following news release: Today, the Federal Trade Commission brought action against the three largest prescription drug benefit managers (PBMs)--Caremark Rx, Express [...]

Published
2024

3. FTC SUES PRESCRIPTION DRUG MIDDLEMEN FOR ARTIFICIALLY INFLATING INSULIN DRUG PRICES

Subjects
Company pricing policy, Health maintenance organizations -- Prices and rates, Diabetes therapy -- Prices and rates, Restraint of trade, Drugs -- Prescribing, Drugstores -- Prices and rates, Group purchasing organizations, Caremark Rx Inc. -- Prices and rates, Express Scripts Inc. -- Prices and rates, United States. Federal Trade Commission
Abstract

WASHINGTON -- The following information was released by the Federal Trade Commission: Caremark, Express Scripts, Optum, and their affiliates created a broken rebate system that inflated insulin drug prices, boosting [...]

Published
2024

4. Federal Trade Commission sues largest drug middlemen for allegedly inflating insulin prices

Subjects
Company pricing policy, Health maintenance organizations -- Prices and rates, Diabetes therapy -- Prices and rates, Drugstores -- Prices and rates, Group purchasing organizations, Insulin -- Prices and rates, Pharmaceutical industry -- Prices and rates, CVS Health Corp. -- Prices and rates, Caremark Rx Inc. -- Prices and rates, Express Scripts Inc. -- Prices and rates, UnitedHealth Group Inc. -- Prices and rates, United States. Federal Trade Commission
Abstract

Byline: Tami Luhby, CNN (CNN) -- (CNN) — The Federal Trade Commission took action Friday against the nation's three largest pharmacy benefit managers, accusing the companies of artificially inflating insulin [...]

Published
2024

5. The Opaque Industry Secretly Inflating Prices for Prescription Drugs

Author

Robbins, Rebecca and Abelson, Reed

Subjects
CVS Health Corp. -- Prices and rates, CIGNA Corp. -- Prices and rates, Express Scripts Inc. -- Prices and rates, UnitedHealth Group Inc. -- Prices and rates, Health maintenance organizations -- Prices and rates, Employers, Drugs -- Prescribing, Drugstores -- Prices and rates, Americans, Company pricing policy, General interest, Humira (Medication) -- Prices and rates
Abstract

Byline: Rebecca Robbins and Reed Abelson Americans are paying too much for prescription drugs. It is a common, longstanding complaint. And the culprits seem obvious: Drug companies. Insurers. A dysfunctional [...]

Published
2024

6. Q2 2023 Kroger Co Earnings Call - Final

Subjects
Express Scripts Inc. -- Prices and rates, Health maintenance organizations -- Prices and rates, Patient compliance, Supermarkets -- Prices and rates, Company pricing policy, Business
Abstract

Presentation OPERATOR: Good morning, and welcome to The Kroger Co. Second Quarter 2023 Earnings Conference Call. Please note, this event is being recorded. I would now like to turn the [...]

Published
2023

7. Q1 2023 Kroger Co Earnings Call - Final

Subjects
Express Scripts Inc. -- Prices and rates, Health maintenance organizations -- Prices and rates, Investment analysis -- Prices and rates, Supermarkets -- Prices and rates, Company pricing policy, Business
Abstract

Presentation OPERATOR: Good morning, and welcome to The Kroger Co. First Quarter 2023 Earnings Conference Call. (Operator Instructions) Please note, this event is being recorded. I would now like to [...]

Published
2023

8. The evolving war on drug prices: immuno-oncology drugs are demonstrating patient benefits, but growing resistance to the high cost has implications for patients, market access, and manufacturers

Author

Kuchenreuther, Michael J.

Subjects
Merck KGaA -- Prices and rates, Bristol-Myers Squibb Co. -- Prices and rates, Express Scripts Inc. -- Prices and rates, Sanofi S.A. -- Prices and rates, Health maintenance organizations -- Prices and rates, Pharmaceutical industry -- Prices and rates, Company pricing policy, Biotechnology industry, Business, Pharmaceuticals and cosmetics industries, European Society for Medical Oncology
Abstract

Over the past few years, the war on drug prices has intensified and been marked by a series of signal events--for example, oncologists publically refusing to allow a pricey new [...]

Published
2016

9. STATES STEP UP PUSH TO REGULATE PHARMACY DRUG BROKERS

Subjects
CVS Health Corp. -- Prices and rates, Express Scripts Inc. -- Prices and rates, Health maintenance organizations -- Prices and rates, Health insurance industry -- Prices and rates, Drugs -- Prescribing, Drugstores -- Prices and rates, Brokers, Company pricing policy, News, opinion and commentary
Abstract

HELENA, MT -- The following information was released by the Montana Commissioner of Securities and Insurance: Under pressure to rein in skyrocketing prescription drug costs, states are targeting companies that [...]

Published
2021

10. Express Scripts To Cut Rates On About 40 Popular Drugs

Author

Thomas, Katie

Subjects
Express Scripts Inc. -- Prices and rates, Drugs -- Prices and rates, Health maintenance organizations -- Prices and rates, Company pricing policy, General interest, News, opinion and commentary
Abstract

It is one of the most acute indignities of being uninsured in this country: Those with the least ability to pay are asked to spend the most for their prescription [...]

Published
2017

11. Cigna's $67 billion acquisition of Express Scripts will change the way drug prices get calculated

Subjects
CVS Health Corp. -- Prices and rates, Elevance Health Inc. -- Prices and rates, CIGNA Corp. -- Prices and rates, E*TRADE Financial Corp. -- Prices and rates, Express Scripts Inc. -- Prices and rates, Aetna Inc. -- Prices and rates, UnitedHealth Group Inc. -- Prices and rates, Health maintenance organizations -- Prices and rates, Health insurance industry -- Prices and rates, Drugstores -- Prices and rates, Insurance industry -- Prices and rates, Securities industry -- Prices and rates, Securities industry, Insurance industry, Company pricing policy, General interest, News, opinion and commentary
Abstract

New York City: E*TRADE Financial Corporation (ETFC) has issued the following press release: Cigna Corp.'s $67 billion acquisition of middleman pharmacy-benefit manager Express Scripts Holding Company, announced Thursday, marks the [...]

Published
2018

12. Pharmacy deal alters field for costly drugs; Some hepatitis medicine is barred after discount is negotiated with a rival

Author

Pollack, Andrew

Subjects
Express Scripts Inc. -- Prices and rates, Health maintenance organizations -- Prices and rates, Drugs -- Prices and rates, Hepatitis C, Company pricing policy, General interest
Abstract

Byline: ANDREW POLLACK In a sign that price competition may take hold for hepatitis C drugs, the largest manager of prescriptions in the United States will require all patients to [...]

Published
2014

13. New hepatitis C drug Sovaldi raises workers compensation cost concerns

Subjects
Gilead Sciences Inc. -- Prices and rates, Express Scripts Inc. -- Prices and rates, Health maintenance organizations -- Prices and rates -- Economic aspects, Biological products industry -- Economic aspects -- Prices and rates, Workers' compensation -- Prices and rates -- Economic aspects, Hepatitis C -- Economic aspects, Company pricing policy, Business, international, Law, Sovaldi (Medication) -- Prices and rates
Abstract

A federal lawsuit alleging price gouging by the maker of hepatitis C drug Sovaldi mirrors a growing struggle to contain hepatitis C-related workers compensation prescription costs that can reach up [...]

Published
2014

14. Lawsuit alleges big PBMs have inflated prescription prices. (RX/Government)

Subjects
Express Scripts Inc. -- Prices and rates, Express Scripts Inc. -- Cases, Caremark Rx Inc. -- Prices and rates, Caremark Rx Inc. -- Cases, AdvancePCS Inc. -- Prices and rates, AdvancePCS Inc. -- Cases, Medco Health Solutions Inc. -- Prices and rates, Medco Health Solutions Inc. -- Cases, Prescription drug plans -- Prices and rates, Prescription drug plans -- Cases, Health insurance industry -- Prices and rates, Health insurance industry -- Cases, Company legal issue, Company pricing policy, Business, Pharmaceuticals and cosmetics industries, Retail industry
Abstract

LOS ANGELES -- The nation's four largest pharmacy benefits managers (PBMs) have been charged with inflating prescription prices in a lawsuit alleging secret deals between the four and some of [...]

Published
2003

15. The nation's four largest PBM firms--AdvancePCS. (Financials)

Subjects
AdvancePCS Inc. -- Cases, AdvancePCS Inc. -- Prices and rates, Caremark Rx Inc. -- Cases, Caremark Rx Inc. -- Prices and rates, Express Scripts Inc. -- Cases, Express Scripts Inc. -- Prices and rates, Health care industry -- Cases, Health care industry -- Prices and rates, Health maintenance organizations -- Cases, Health maintenance organizations -- Prices and rates, Price gouging -- Cases, Health care industry, Company pricing policy, Company legal issue, Business, Pharmaceuticals and cosmetics industries, Retail industry
Abstract

LOS ANGELES -- The nation's four largest PBM firms--AdvancePCS, Medco, Express Scripts and Caremark Rx-have been charged with inflating prescription drug prices in a lawsuit filed last week by the [...]

Published
2003

Catalog

Books, media, physical & digital resources
See catalog results